← FDA Drug Approvals (Drugs@FDA)

RIOCIGUAT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2022-09-01

Drug application

FDA Application #

ANDA211135

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIOCIGUAT

Generic name

Riociguat

Active ingredients

RIOCIGUAT

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MSN

First approval

2022-09-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown